Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function Genotype: a Validation Study in Patients With Stable Coronary Artery Disease
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 09 Jan 2019 Planned End Date changed from 1 Aug 2019 to 1 May 2020.
- 09 Jan 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Jan 2020.
- 31 Aug 2018 Biomarkers information updated